FUT2 and cystic fibrosis: Moreover, variants in both FUT2 and FUT3 have been shown in GWAS to increase susceptibility to diseases associated with both mucosal surface pathobiology and microbiome composition, such as cystic fibrosis [39], Crohn’s disease [63], and ulcerative colitis [64].